Viewing StudyNCT00168766



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00168766
Status: COMPLETED
Last Update Posted: 2013-09-16
First Post: 2005-09-13

Brief Title: Avonex Interferon-beta-1a and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS
Sponsor: Biogen
Organization: Biogen

Conditions & Keywords Data

Conditions:
Name
Relapsing-remitting Multiple Sclerosis
Keywords:
Name View
Combination therapy for multiple sclerosis View